Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniofacial Abnormalities | 2 | 2014 | 21 | 0.920 |
Why?
|
| Bacteria | 2 | 2020 | 245 | 0.740 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 78 | 0.720 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 203 | 0.710 |
Why?
|
| Neural Tube | 2 | 2016 | 7 | 0.650 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 355 | 0.590 |
Why?
|
| Encephalocele | 1 | 2014 | 4 | 0.510 |
Why?
|
| Facial Bones | 1 | 2014 | 13 | 0.500 |
Why?
|
| Lipoma | 1 | 2012 | 4 | 0.430 |
Why?
|
| Congenital Abnormalities | 1 | 2012 | 19 | 0.420 |
Why?
|
| Military Personnel | 2 | 2024 | 67 | 0.420 |
Why?
|
| Mutation | 2 | 2016 | 1023 | 0.420 |
Why?
|
| Protein-Lysine 6-Oxidase | 6 | 2013 | 64 | 0.410 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 105 | 0.390 |
Why?
|
| Amino Acid Oxidoreductases | 5 | 2013 | 33 | 0.330 |
Why?
|
| Tropoelastin | 2 | 2007 | 13 | 0.320 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2007 | 22 | 0.300 |
Why?
|
| Lung | 1 | 2007 | 413 | 0.240 |
Why?
|
| Mice | 9 | 2016 | 5668 | 0.220 |
Why?
|
| Epithelial Cells | 3 | 2020 | 366 | 0.210 |
Why?
|
| Mycoplasma Infections | 1 | 2021 | 4 | 0.210 |
Why?
|
| Mycoplasma genitalium | 1 | 2021 | 3 | 0.210 |
Why?
|
| Bacteriological Techniques | 1 | 2020 | 13 | 0.190 |
Why?
|
| Electric Impedance | 1 | 2020 | 23 | 0.190 |
Why?
|
| Cell Physiological Phenomena | 1 | 2020 | 8 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 283 | 0.190 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 47 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2013 | 160 | 0.180 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2020 | 100 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 1300 | 0.180 |
Why?
|
| Animals | 11 | 2016 | 14307 | 0.180 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 555 | 0.170 |
Why?
|
| Transcription Factors | 3 | 2016 | 653 | 0.160 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 152 | 0.150 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 901 | 0.150 |
Why?
|
| Ectoderm | 1 | 2016 | 11 | 0.140 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 18 | 0.140 |
Why?
|
| Body Size | 1 | 2016 | 28 | 0.140 |
Why?
|
| Homozygote | 1 | 2016 | 75 | 0.140 |
Why?
|
| Point Mutation | 1 | 2016 | 88 | 0.140 |
Why?
|
| Cell Polarity | 1 | 2016 | 53 | 0.140 |
Why?
|
| Humans | 14 | 2024 | 34853 | 0.130 |
Why?
|
| Anencephaly | 1 | 2014 | 4 | 0.130 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2014 | 3 | 0.130 |
Why?
|
| Bone Development | 1 | 2014 | 15 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2004 | 45 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 229 | 0.120 |
Why?
|
| Placentation | 1 | 2013 | 7 | 0.120 |
Why?
|
| RNA | 1 | 2016 | 234 | 0.120 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 45 | 0.120 |
Why?
|
| Trophoblasts | 1 | 2013 | 22 | 0.120 |
Why?
|
| PPAR gamma | 1 | 2013 | 49 | 0.120 |
Why?
|
| Models, Biological | 1 | 2016 | 642 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 522 | 0.110 |
Why?
|
| Corpus Callosum | 1 | 2012 | 12 | 0.110 |
Why?
|
| Face | 1 | 2012 | 49 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 206 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2005 | 968 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 649 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 600 | 0.090 |
Why?
|
| Gestational Age | 2 | 2007 | 190 | 0.090 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 39 | 0.090 |
Why?
|
| Amine Oxidase (Copper-Containing) | 1 | 2008 | 5 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 468 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 211 | 0.080 |
Why?
|
| Biliary Atresia | 1 | 2007 | 4 | 0.080 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2007 | 5 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2009 | 859 | 0.080 |
Why?
|
| Mesoderm | 1 | 2007 | 70 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2007 | 871 | 0.080 |
Why?
|
| Pancreatic Elastase | 1 | 2007 | 7 | 0.080 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2007 | 31 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 37 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 31 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 183 | 0.070 |
Why?
|
| Sheep | 1 | 2007 | 70 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2007 | 22 | 0.070 |
Why?
|
| Fibrosis | 1 | 2007 | 146 | 0.070 |
Why?
|
| Serine | 1 | 2007 | 72 | 0.070 |
Why?
|
| Peroxidase | 1 | 2007 | 50 | 0.070 |
Why?
|
| Pregnancy | 2 | 2013 | 1503 | 0.070 |
Why?
|
| Superoxide Dismutase | 2 | 2004 | 149 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 157 | 0.070 |
Why?
|
| Esophageal Neoplasms | 1 | 2007 | 124 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2007 | 323 | 0.070 |
Why?
|
| Oxygen | 1 | 2007 | 193 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 51 | 0.070 |
Why?
|
| Cell Line | 3 | 2020 | 1289 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 181 | 0.070 |
Why?
|
| Cadherins | 1 | 2005 | 82 | 0.070 |
Why?
|
| Fibronectins | 1 | 2005 | 65 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2005 | 53 | 0.060 |
Why?
|
| Muscle Weakness | 1 | 2004 | 7 | 0.060 |
Why?
|
| Carcinoma | 1 | 2005 | 94 | 0.060 |
Why?
|
| Cyclosporine | 1 | 2004 | 26 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2004 | 121 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2009 | 834 | 0.060 |
Why?
|
| Indonesia | 1 | 2024 | 10 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2007 | 562 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2005 | 179 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2024 | 165 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2004 | 130 | 0.060 |
Why?
|
| Female | 6 | 2021 | 19873 | 0.060 |
Why?
|
| Longevity | 1 | 2004 | 143 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 605 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 231 | 0.050 |
Why?
|
| Chlamydia trachomatis | 1 | 2021 | 66 | 0.050 |
Why?
|
| Enterococcus | 1 | 2020 | 6 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2020 | 22 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2020 | 24 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2020 | 57 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 80 | 0.040 |
Why?
|
| Azacitidine | 2 | 2009 | 21 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 81 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1426 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 6448 | 0.040 |
Why?
|
| Hawaii | 1 | 2024 | 1878 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2021 | 1353 | 0.040 |
Why?
|
| Catalysis | 2 | 2009 | 162 | 0.040 |
Why?
|
| Glutathione Transferase | 2 | 2008 | 83 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2020 | 436 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1425 | 0.040 |
Why?
|
| Cytokines | 1 | 2020 | 569 | 0.040 |
Why?
|
| DNA Primers | 2 | 2007 | 269 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 210 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 3414 | 0.030 |
Why?
|
| Middle Aged | 3 | 2021 | 9642 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 5035 | 0.030 |
Why?
|
| Male | 5 | 2021 | 18870 | 0.030 |
Why?
|
| Aminopropionitrile | 1 | 2013 | 13 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 24 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 48 | 0.030 |
Why?
|
| Placenta | 1 | 2013 | 91 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 286 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 608 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 4012 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 2128 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 11034 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 30 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2008 | 9 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2008 | 58 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2008 | 33 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2008 | 89 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 111 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 18 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 72 | 0.020 |
Why?
|
| Rats | 2 | 2005 | 3261 | 0.020 |
Why?
|
| CpG Islands | 1 | 2007 | 91 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 63 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 126 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 49 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 126 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 185 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2005 | 202 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 484 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2005 | 170 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 195 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 175 | 0.020 |
Why?
|
| Anterior Horn Cells | 1 | 2004 | 5 | 0.020 |
Why?
|
| Lysine | 1 | 2005 | 104 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 60 | 0.020 |
Why?
|
| Hindlimb | 1 | 2004 | 26 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 298 | 0.020 |
Why?
|
| RNA Interference | 1 | 2005 | 225 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2004 | 197 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2004 | 41 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 240 | 0.020 |
Why?
|
| Transfection | 1 | 2005 | 496 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 145 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 286 | 0.020 |
Why?
|
| Propidium | 1 | 2004 | 18 | 0.020 |
Why?
|
| Infant | 1 | 2007 | 1014 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 383 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 125 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 117 | 0.020 |
Why?
|
| Kinetics | 1 | 2005 | 650 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 274 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 135 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2005 | 252 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 1318 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 404 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 913 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 984 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 781 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 393 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 490 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 818 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 2333 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1007 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1152 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 1530 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 1802 | 0.010 |
Why?
|
| Aging | 1 | 2004 | 639 | 0.010 |
Why?
|
| Child | 1 | 2007 | 2875 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 1681 | 0.010 |
Why?
|
| Neurons | 1 | 2004 | 1130 | 0.010 |
Why?
|